Altus Wealth Group’s Colgate-Palmolive CL Stock Holding History

Altus Wealth Group’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-164	Closed	-$14K	–	282
2020 Q4	$14K	Buy	+164	New	+$13.6K	0.01%	446

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Altus Wealth Group's CL Position: Q1 2021 in Review

Altus Wealth Group sold out of Colgate-Palmolive (CL) in Q1 2021, closing a stake of 164 shares — an estimated $14K sold.

Altus Wealth Group first reported a position in CL in Q4 2020 and held it in 1 quarter. The position peaked at $14K in Q4 2020. 1,608 funds tracked by Wall St. Rank hold CL as of Q1 2021.

Altus Wealth Group reported no remaining Colgate-Palmolive position as of Q1 2021 after selling out during the quarter.
Altus Wealth Group sold 164 Colgate-Palmolive shares in Q1 2021, an estimated $14K.
Altus Wealth Group first reported a position in Colgate-Palmolive in Q4 2020 and held it in 1 quarter.
Altus Wealth Group's Colgate-Palmolive position peaked at $14K in Q4 2020.
1,608 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2021.

Based on Altus Wealth Group's 13F filing for Q1 2021, filed 14 May 2021.